Pinealon: How It Works, What It's Studied For & Safety
Pinealon is a short pineal-derived peptide bioregulator studied alongside Epithalon in Russian gerontology research for circadian and neuroprotective effects. Clinicians consider it for sleep architecture and circadian-rhythm research. It is not FDA-approved as a finished drug product and is dispensed by Wells Pharmacy Network only after a licensed clinician evaluates intake, history, and labs.
Also known as: Glu-Asp-Arg, EDR tripeptide
How does Pinealon work?
Pinealon is a Glu-Asp-Arg tripeptide studied for cell-permeant signaling effects on neuronal cells and modulation of melatonin-related pathways. Mechanistic understanding outside the originating Russian research lineage is limited.
What is Pinealon studied for?
- Sleep architecture and circadian-rhythm research
- Neuroprotection in aging research models
How is Pinealon taken?
Compounded as a subcutaneous injection in short, pulsed courses (commonly 10-20 days).
Is Pinealon FDA-approved? Is it safe?
Not FDA-approved for the prevention, treatment, or cure of any condition. Used inside research-informed, clinician-directed protocols only. Independent replication of the Russian research base is limited. Compounded prescription-only preparations are dispensed by Wells Pharmacy Network. Eligibility is decided by a licensed clinician based on intake and labs, not by checkout. Compounded products on this site are not FDA-approved and are not generic equivalents of any branded medication.
In the Regen Therapy catalog
This compound does not currently appear in an active Regen Therapy protocol. Browse the full catalog for adjacent options.
What does the research say about Pinealon?
Concentrated in a single research lineage. Considered investigational.
Citations & further reading
Considering Pinealon as part of a protocol?
Browse Regen Therapy's catalog or start a clinician evaluation. Every prescription is reviewed by a licensed clinician and dispensed by Wells Pharmacy Network.
Browse the catalog →